Plastic, Reconstructive and Cosmetic Surgery Risk Assessment: Patient Safety, Consent and Continuity Controls

This assessment shows how a plastic, reconstructive and cosmetic surgery service can find, rate and control the risks that matter most to patients. Eight risks were chosen because they are plausible in planned surgical work, from operative complications and consent to devices, records and staffing. Operative complications and expectation mismatch are the most visible, while device recall and data exposure are less likely but can affect many patients. Each risk is scored before controls and again after existing and added controls. Most risks fall to Medium or Low once added controls are in place, but surgical complications stay at Medium because the harm to a patient is serious even when it is uncommon. The first actions are a checklist audit, a consent standard for cosmetic cases, a device traceability log and a tested backup. Specialist clinical review is needed for any real service, and every score here illustrates method, not a real organization.

Scope

This assessment covers a surgical service that performs planned plastic, reconstructive and cosmetic procedures, from referral and consent through the operating room, recovery and follow up. It looks at risks to patient safety, informed decisions, staff competence, records, devices and service continuity. It does not give clinical guidance on any procedure. Jurisdiction, facility type, case mix and systems are assumptions made for teaching and must be replaced by local facts.

Context

The service has consultant plastic surgeons, surgeons in training, operating room nurses, anesthesia staff, a clinic coordinator and a small team that manages implants and device stock. Procedures range from skin and breast reconstruction to aesthetic operations done under general or local anesthesia. Patient records, photographs and imaging are held in an electronic system, and some implants and dressings come from external suppliers. Each risk is scored before controls to show its natural level, then again after existing controls and the controls that should be added.

Objectives, assets and stakeholders

The objective is to deliver safe, well planned surgery, give patients informed choices, keep staff competent and protect records, devices and service continuity. The assets in scope are patients and their safety, operating room and recovery facilities, surgical instruments and implants, clinical records and images, and the reputation of the surgical team. Stakeholders include patients and their families, surgeons and operating room staff, anesthesia staff, the clinic coordinator, device suppliers, the governance committee, regulators and insurers. Every risk has one owner role. The clinical governance lead keeps the register current and reports to the governance committee each quarter.

Each risk is rated on two five-point scales. Likelihood runs from Rare to Almost certain, and impact runs from Negligible to Catastrophic. Multiplying the two gives a score from 1 to 25, which falls into one of four bands: Low from 1 to 4, Medium from 5 to 9, High from 10 to 16 and Critical from 17 to 25. The score guides the order of work and is not a measurement. Inherent risk is the score before any controls, and residual risk is the score after existing controls and the added controls are in place. Impact for patients is judged on physical harm, distress, time to recover, the effect on the wider service and loss of trust, and a risk is never rated down only because it has not yet happened. Anything still Critical or High needs senior surgical attention and a dated plan. Medium risks need routine controls with a named owner, and Low risks are accepted and watched. Surgeons, nurses and patient representatives should challenge each rating, and every score is reviewed whenever an indicator reaches its threshold.

Contingency arrangements

If a serious event occurs, such as a patient harm event, a device recall or a data breach, the consultant in charge pauses related lists and secures the affected records. The clinical governance lead informs the medical director and the risk owner the same day, and families receive an honest and timely explanation. Affected devices are quarantined, and records are restored from the latest tested backup. Legal, insurer and regulator contacts are made through the medical director as required in the relevant jurisdiction. Patient transfer arrangements with a partner hospital are used when on-site care is not enough.

Conclusion

Safe surgery depends on steady habits: a checked safety checklist for every case, a clear consent process, competence records that are kept current, traceable devices, tested backups and a practiced transfer plan. The highest scores sit with operative complications, consent and the competence of the team, and each has controls that bring the residual score down. Treat the register as a living record, review it on the stated cycle, and seek qualified clinical, legal and data protection advice for any real decision.